| [1] |
Jemal A,Siegel R,Ward E,et al.Cancer statistics,2007[J].CA Cancer J Clin,2007,57(1)：43-66.
|
| [2] |
Grundmann RT,Hermanek P,Merkel S,et al.Diagnosis and treatment of colorectal liver metastases-workflow[J].Zentralbl Chir,2008,133(3)：267-84.
|
| [3] |
Seki T,Wakabayashi M,Nakagawa T,et al.Ultrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinoma[J].Cancer,1994,74(3)：817-25.
|
| [4] |
Lv MD.Clinical efficacy and status of image-guided ablation of liver cancer[J]. Zhongguo Pu Wai Ji Chu Yu Lin Chuang Za Zhi,2006,13(2)：138-9.[吕明德.影像引导肝癌消融治疗的效果和临床地位[J].中 国普外基础与临床杂志，2006，13(2)：138-9. ]
|
| [5] |
Liu LX,Huang PW,Shu YQ, et al.Oxaliplatin,leucovorin joint for fluoride injection with FOLFOX4 treatment of advanced colorectal[J].Jiangsu Yi Yao,2006,32(4)：390-1.[刘凌翔，黄普文，束永前，等.草酸铂、亚叶酸钙联合替加氟注射 液与FOLFOX4方案治疗晚期大肠癌[J].江苏医药，2006，32(4)：390-1.]
|
| [6] |
Grothey A,Sargent D.Overall survival of patients with advanced colorectal cancer correlates with availability of fluorouracil,irinotecan,and oxaliplatin regardless of whether doublet or single-agent therapy is used first line[J].J Clin Oncol,2005,23(36)：9441-2.
|
| [7] |
Grothey A,Sargent D,Goldberg RM,et al.Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin,irinotecan,and oxaliplatin in the course of treatment [J].J Clin Oncol,2004,22 (7)：1209-14.
|
| [8] |
Tanaka F,Fukuse T,Wada H,et al.The history,mechanism and clinical use of oral 5-fluorouracil derivative chemotherapeutic agents[J].Curr Pharm Biotechnol,2000,1(2)：137-64.
|
| [9] |
Ueno H,Okusaka T,Ikeda M,et al.Phase II study of S-1 in patients with advanced biliary tract cancer[J].Br J Cancer,2004,91(10)：1769-74．
|
| [10] |
Neoptolemos JP,Stocken DD,Friess H,et al.A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer [J]．N Engl J Med,2004,350 (12)：1200-10．
|
| [11] |
Oettle H,Post S,Neuhaus P,et al.Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer：a randomized controlledtrial[J].JAMA,2007,297(3)：267-77．
|
| [12] |
Stocken DD,Buchler MW,Dervenis C,et al.Meta -analysis of randomised adjuvant therapy trials for pancreatic cancer[J].Br J Cancer,2005,92 (8)：1372-81.
|
| [13] |
Van den Brande J,Schffski P,Schellens JH,et al.EORTC Early Clinical Studies Group early phase II trial of S-1 in patients with advanced or metastatic colorectal cancer [J].Br J Cancer,2003,88(5)：648-53．
|
下载:
